IBDEI1SZ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30641,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec
 ;;^UTILITY(U,$J,358.3,30641,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,30641,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,30642,0)
 ;;=C81.99^^121^1524^2
 ;;^UTILITY(U,$J,358.3,30642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30642,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal & Solid Organ Sites,Unspec
 ;;^UTILITY(U,$J,358.3,30642,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,30642,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,30643,0)
 ;;=E86.1^^121^1525^13
 ;;^UTILITY(U,$J,358.3,30643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30643,1,3,0)
 ;;=3^Hypovolemia
 ;;^UTILITY(U,$J,358.3,30643,1,4,0)
 ;;=4^E86.1
 ;;^UTILITY(U,$J,358.3,30643,2)
 ;;=^332744
 ;;^UTILITY(U,$J,358.3,30644,0)
 ;;=E85.9^^121^1525^2
 ;;^UTILITY(U,$J,358.3,30644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30644,1,3,0)
 ;;=3^Amyloidosis,Unspec
 ;;^UTILITY(U,$J,358.3,30644,1,4,0)
 ;;=4^E85.9
 ;;^UTILITY(U,$J,358.3,30644,2)
 ;;=^334185
 ;;^UTILITY(U,$J,358.3,30645,0)
 ;;=J34.9^^121^1525^14
 ;;^UTILITY(U,$J,358.3,30645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30645,1,3,0)
 ;;=3^Nose & Nasal Sinuses Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,30645,1,4,0)
 ;;=4^J34.9
 ;;^UTILITY(U,$J,358.3,30645,2)
 ;;=^5008212
 ;;^UTILITY(U,$J,358.3,30646,0)
 ;;=Q21.1^^121^1525^6
 ;;^UTILITY(U,$J,358.3,30646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30646,1,3,0)
 ;;=3^Atrial Septal Defect
 ;;^UTILITY(U,$J,358.3,30646,1,4,0)
 ;;=4^Q21.1
 ;;^UTILITY(U,$J,358.3,30646,2)
 ;;=^186788
 ;;^UTILITY(U,$J,358.3,30647,0)
 ;;=R56.9^^121^1525^8
 ;;^UTILITY(U,$J,358.3,30647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30647,1,3,0)
 ;;=3^Convulsions,Unspec
 ;;^UTILITY(U,$J,358.3,30647,1,4,0)
 ;;=4^R56.9
 ;;^UTILITY(U,$J,358.3,30647,2)
 ;;=^5019524
 ;;^UTILITY(U,$J,358.3,30648,0)
 ;;=R57.0^^121^1525^7
 ;;^UTILITY(U,$J,358.3,30648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30648,1,3,0)
 ;;=3^Cardiogenic Shock
 ;;^UTILITY(U,$J,358.3,30648,1,4,0)
 ;;=4^R57.0
 ;;^UTILITY(U,$J,358.3,30648,2)
 ;;=^5019525
 ;;^UTILITY(U,$J,358.3,30649,0)
 ;;=T79.4XXA^^121^1525^17
 ;;^UTILITY(U,$J,358.3,30649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30649,1,3,0)
 ;;=3^Traumatic Shock,Init Encnt
 ;;^UTILITY(U,$J,358.3,30649,1,4,0)
 ;;=4^T79.4XXA
 ;;^UTILITY(U,$J,358.3,30649,2)
 ;;=^5054305
 ;;^UTILITY(U,$J,358.3,30650,0)
 ;;=T78.2XXA^^121^1525^4
 ;;^UTILITY(U,$J,358.3,30650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30650,1,3,0)
 ;;=3^Anaphylactic Shock,Unspec,Init Encnt
 ;;^UTILITY(U,$J,358.3,30650,1,4,0)
 ;;=4^T78.2XXA
 ;;^UTILITY(U,$J,358.3,30650,2)
 ;;=^5054278
 ;;^UTILITY(U,$J,358.3,30651,0)
 ;;=T50.905A^^121^1525^1
 ;;^UTILITY(U,$J,358.3,30651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30651,1,3,0)
 ;;=3^Adverse Effect Drug/Meds/Biol Substance,Init Encnt
 ;;^UTILITY(U,$J,358.3,30651,1,4,0)
 ;;=4^T50.905A
 ;;^UTILITY(U,$J,358.3,30651,2)
 ;;=^5052160
 ;;^UTILITY(U,$J,358.3,30652,0)
 ;;=T88.4XXA^^121^1525^10
 ;;^UTILITY(U,$J,358.3,30652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30652,1,3,0)
 ;;=3^Failed/Difficult Intubation,Init Encnt
 ;;^UTILITY(U,$J,358.3,30652,1,4,0)
 ;;=4^T88.4XXA
 ;;^UTILITY(U,$J,358.3,30652,2)
 ;;=^5055796
 ;;^UTILITY(U,$J,358.3,30653,0)
 ;;=T88.59XA^^121^1525^5
 ;;^UTILITY(U,$J,358.3,30653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30653,1,3,0)
 ;;=3^Anesthesia Complications,Init Encnt
 ;;^UTILITY(U,$J,358.3,30653,1,4,0)
 ;;=4^T88.59XA
 ;;^UTILITY(U,$J,358.3,30653,2)
 ;;=^5055805
 ;;^UTILITY(U,$J,358.3,30654,0)
 ;;=T88.6XXA^^121^1525^3
 ;;^UTILITY(U,$J,358.3,30654,1,0)
 ;;=^358.31IA^4^2
